{"filing":{"accession_number":"0001193125-26-275811","cik":"0001759425","ticker":"MIRM","company_name":"Mirum Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"d74563d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/d74563d8k.htm"},"events":[{"id":11813,"run_id":10391,"accession_number":"0001193125-26-275811","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 filing discloses the results of Mirum Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 15, 2026, including voting outcomes for three proposals: election of three Class I directors (Lon Cardon, William Fairey, and Timothy Walbert), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies for each proposal are the core disclosure, making this a textbook shareholder_vote_results event.","company_name":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8496,"accession_number":"0001193125-26-275811","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the results of Mirum Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 15, 2026, including voting outcomes for three proposals: election of three Class I directors (Lon Cardon, William Fairey, and Timothy Walbert), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies for each proposal are the core disclosure, making this a textbook shareholder_vote_results event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:07:57.863201+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8496,"accession_number":"0001193125-26-275811","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the results of Mirum Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 15, 2026, including voting outcomes for three proposals: election of three Class I directors (Lon Cardon, William Fairey, and Timothy Walbert), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies for each proposal are the core disclosure, making this a textbook shareholder_vote_results event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:07:57.863201+00:00","company_name":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","filing_date":"2026-06-18"}]}